Skip to main content
  • Back
    About us
    • Purpose and Strategy
    • Corporate Governance
      • Board of Directors
      • Executive Committee
    • Environmental, Social and Governance
      • Our Business model
      • Our four commitments
      • Non financial key figures
      • ESG Certifications and Performance
      • Resource center
    • Business Ethics and Compliance
      • Nos principes éthiques
      • Our ethical principles
      • Supplier corner
      • Whistleblowing System

    About us

    At EUROAPI, we’re reinventing active ingredient solutions to meet customers’ and patients’ needs around the world in a sustainable way.

  • Back
    API Solutions
    • API List
    • Vitamin B12
    • Prostaglandins
    • Corticoids & Hormones
    • Anti Infectives
    • Opiates & Controlled Substances
    • Small and Complex Molecules
    • Products under development
    • Intermediates and Reagents List

    API Solutions

    Euroapi offers the largest portfolio of APIs in the world, counting upwards of 200 ingredients, addressing a wide population of patients and providing global coverage for more than 80 countries.

  • Back
    CDMO services
    • Tides | CDMO
      • Oligonucleotides
    • Small Molecules Synthesis | CDMO
    • Lipids | CDMO
    • Particle Engineering | CDMO
      • Micronization capability
      • Spray drying capability
    • Microbial Fermentation | CDMO
      • Enzymes
    • Prostaglandins | CDMO
    • Steroids and Hormones | CDMO

    CDMO services

  • Industrial Footprint
    Back
    Industrial Footprint

    Industrial Footprint

  • Careers
    Back
    Careers

    Careers

  • Back
    Investors
    • Publications and Events
      • Calendar
      • Results
      • Press releases
      • Investor presentations
    • Stock information
      • Share data
      • Shareholding structure
      • Dividend
      • Becoming a shareholder
    • Share coverage
      • Analyst coverage
      • Consensus
    • Regulatory information
      • Press releases
      • Annual General Meetings
      • Financial reports
      • Voting rights and shares
      • Liquidity Contract
      • Other legal and corporate documents
    • Corporate Governance
      • Board of Directors
      • Executive Committee
      • Other documents
      • Business Ethics and Compliance
    • Environmental, Social and Governance
      • Our Business model
      • Our four commitments
      • Non financial key figures
      • ESG Certifications and Performance
      • Resource center

    Investors

    You are an investor, an analyst or an individual shareholder and have a question about EUROAPI, please contact the Investor Relations department.

    The role of the Investor Relations department is to maintain a transparent and comprehensive dialogue with the financial community about EUROAPI's strategy, outlook and financial data, its economic environment and any other useful information.

     

    Sophie Palliez

    Head of Investor Relations
    ir@euroapi.com

  • Back
    Media
    • Press Releases
    • News
    • Events
    • Images
      • Board of Directors
      • Executive Committee
      • Sites
      • Equipments
    • Subscribe

    Media

    You are a journalist and have a question about Euroapi, please contact the Global Media Relations department.

    Laurence Bollack, Head of Global Media Relations
    +33 (0)6 81 86 80 19 • mr@euroapi.com

    Please note the contact details are only for journalists.

  • Partner with us
    Back
    Partner with us

    Partner with us

  • Back
    About us
    • Purpose and Strategy
    • Corporate Governance
      • Board of Directors
      • Executive Committee
    • Environmental, Social and Governance
      • Our Business model
      • Our four commitments
      • Non financial key figures
      • ESG Certifications and Performance
      • Resource center
    • Business Ethics and Compliance
      • Nos principes éthiques
      • Our ethical principles
      • Supplier corner
      • Whistleblowing System

    About us

    At EUROAPI, we’re reinventing active ingredient solutions to meet customers’ and patients’ needs around the world in a sustainable way.

  • Back
    API Solutions
    • API List
    • Vitamin B12
    • Prostaglandins
    • Corticoids & Hormones
    • Anti Infectives
    • Opiates & Controlled Substances
    • Small and Complex Molecules
    • Products under development
    • Intermediates and Reagents List

    API Solutions

    Euroapi offers the largest portfolio of APIs in the world, counting upwards of 200 ingredients, addressing a wide population of patients and providing global coverage for more than 80 countries.

  • Back
    CDMO services
    • Tides | CDMO
      • Oligonucleotides
    • Small Molecules Synthesis | CDMO
    • Lipids | CDMO
    • Particle Engineering | CDMO
      • Micronization capability
      • Spray drying capability
    • Microbial Fermentation | CDMO
      • Enzymes
    • Prostaglandins | CDMO
    • Steroids and Hormones | CDMO

    CDMO services

  • Industrial Footprint
    Back
    Industrial Footprint

    Industrial Footprint

  • Careers
    Back
    Careers

    Careers

  • Back
    Investors
    • Publications and Events
      • Calendar
      • Results
      • Press releases
      • Investor presentations
    • Stock information
      • Share data
      • Shareholding structure
      • Dividend
      • Becoming a shareholder
    • Share coverage
      • Analyst coverage
      • Consensus
    • Regulatory information
      • Press releases
      • Annual General Meetings
      • Financial reports
      • Voting rights and shares
      • Liquidity Contract
      • Other legal and corporate documents
    • Corporate Governance
      • Board of Directors
      • Executive Committee
      • Other documents
      • Business Ethics and Compliance
    • Environmental, Social and Governance
      • Our Business model
      • Our four commitments
      • Non financial key figures
      • ESG Certifications and Performance
      • Resource center

    Investors

    You are an investor, an analyst or an individual shareholder and have a question about EUROAPI, please contact the Investor Relations department.

    The role of the Investor Relations department is to maintain a transparent and comprehensive dialogue with the financial community about EUROAPI's strategy, outlook and financial data, its economic environment and any other useful information.

     

    Sophie Palliez

    Head of Investor Relations
    ir@euroapi.com

  • Back
    Media
    • Press Releases
    • News
    • Events
    • Images
      • Board of Directors
      • Executive Committee
      • Sites
      • Equipments
    • Subscribe

    Media

    You are a journalist and have a question about Euroapi, please contact the Global Media Relations department.

    Laurence Bollack, Head of Global Media Relations
    +33 (0)6 81 86 80 19 • mr@euroapi.com

    Please note the contact details are only for journalists.

  • Partner with us
    Back
    Partner with us

    Partner with us

  • en
  • fr
  • hu
  • it
  • de
  • EN
  • FR
Breadcrumb
  1. Home
  2. Investors
  3. Publications and Events
  4. Results
  5. EUROAPI 2023 Half Year Results
Breadcrumb
  1. Home
  2. Investors
  3. Publications and Events
  4. Results
  5. EUROAPI 2023 Half Year Results

results

EUROAPI 2023 Half year results

Available downloads

  • EUROAPI H1 2023 Results

    pdf

    273.26Ko

  • EUROAPI_H1 2023 Results_Presentation_01AUG23_EN

    pdf

    1555.78Ko

  • Transcript EUROAPI H1 2023_EN

    pdf

    536.36Ko

  • Half-year financial report - EN - 2023.06

    pdf

    2358.02Ko

Webcast

Partner with us

Contact
A girl smiling at another woman in a field
LinkedIn
  • Sitemap
  • Legal notice
  • Data policy
  • Accessibility
  • Cookies Policy
  • Terms and Conditions
© 2024 EUROAPI